These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994 [TBL] [Abstract][Full Text] [Related]
9. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Nygaard B; Hegedüs L; Nielsen KG; Ulriksen P; Hansen JM Clin Endocrinol (Oxf); 1999 Feb; 50(2):197-202. PubMed ID: 10396362 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
11. [Does Iodine 131 treatment of goiter result in an acute increase of the volume and function of the thyroid gland?]. Nygaard B; Faber JO; Hegedüs L Ugeskr Laeger; 1995 Dec; 157(50):7003-6. PubMed ID: 8545918 [TBL] [Abstract][Full Text] [Related]
12. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results]. Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510 [TBL] [Abstract][Full Text] [Related]
13. Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen. Lewis A; Atkinson B; Bell P; Courtney H; McCance D; Mullan K; Hunter S Ulster Med J; 2013 May; 82(2):85-8. PubMed ID: 24082285 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy (I 131). Khanna CM; Magdum M; Ravishankar L; Dham DN; Chugh P J Assoc Physicians India; 1996 Feb; 44(2):102-5. PubMed ID: 10999060 [TBL] [Abstract][Full Text] [Related]
15. Subtle changes in serum thyrotrophin (TSH) and sex-hormone-binding globulin (SHBG) levels during long-term follow-up after radioactive iodine in multinodular non-toxic goitre. Jarløv AE; Faber J; Hegedüs L; Hansen JM Clin Endocrinol (Oxf); 1992 Oct; 37(4):335-7. PubMed ID: 1483288 [TBL] [Abstract][Full Text] [Related]
16. Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy. Kahraman D; Keller C; Schneider C; Eschner W; Sudbrock F; Schmidt M; Schicha H; Dietlein M; Kobe C Clin Endocrinol (Oxf); 2012 Feb; 76(2):297-303. PubMed ID: 21854403 [TBL] [Abstract][Full Text] [Related]
17. Long-term results of two schedules of radioiodine treatment for toxic multinodular goitre. Huysmans DA; Hermus AR; Corstens FH; Kloppenborg PW Eur J Nucl Med; 1993 Nov; 20(11):1056-62. PubMed ID: 8287873 [TBL] [Abstract][Full Text] [Related]
18. Long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy. Khanna CM; Magdam M; Ravishankar L; Dham DN; Chugh P J Assoc Physicians India; 1995 Oct; 43(10):685-8. PubMed ID: 8773004 [TBL] [Abstract][Full Text] [Related]
19. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679 [TBL] [Abstract][Full Text] [Related]
20. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease. Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Hansen BM; Søe-Jensen P; Hansen JM J Intern Med; 1995 Dec; 238(6):491-7. PubMed ID: 9422034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]